From research on thymosin beta-4, TB-500 appears to modulate cell movement, differentiation, and tissue healing
Safety Considerations and Contraindications Who Should Avoid BPC-157 Contraindications : Active cancer diagnosis (due to angiogenic properties) Pregnancy or breastfeeding Severe cardiovascular disease Known hypersensitivity to peptides Drug Interactions BPC-157 has minimal known drug interactions but may potentially interact with: Anticoagulant medications (enhanced healing may affect clotting) Immunosuppressive drugs Other growth factors or healing peptides Medical Supervision Requirements Consult healthcare providers before starting BPC-157 if you have: Chronic medical conditions Recent surgical procedures Blood clotting disorders Current prescription medications Our Clinics Experience with BPC-157 Dosing Through extensive clinical experience with BPC-157 protocols, weve observed optimal healing results with 300 mcg daily split dosing for most applications
Other Ingredients Vehicle (Soya Oil), Capsule Shell (Gelatin), Humectant (Glycerol), Emulsifier (Lecithin), Antioxidant (Astaxanthin), L-Glutathione, Stabilizer (Sorbitol Solution), Suspending Agent (Yellow Beeswax), Purified Water, Ascorbic Acid, D-Alpha Tocopherol, Synthetic Pigment (Titanium Dioxide)
The Down Regulated in Adenoma ( dra ) gene encodes an intestine-specific membrane sulfate transport protein
Double-blind, Randomized Trial on the Effectiveness of Acetylhexapeptide-3 Cream and Palmitoyl Pentapeptide-4 Cream for Crows Feet
